Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	Brensocatib 10 mg	82
Overall Study	STARTED	Brensocatib 25 mg	87
Overall Study	STARTED	Placebo	87
Overall Study	Received Study Treatment (Safety Population)	Brensocatib 10 mg	81
Overall Study	Received Study Treatment (Safety Population)	Brensocatib 25 mg	89
Overall Study	Received Study Treatment (Safety Population)	Placebo	85
Overall Study	Participants Did Not Receive Drug	Brensocatib 10 mg	0
Overall Study	Participants Did Not Receive Drug	Brensocatib 25 mg	0
Overall Study	Participants Did Not Receive Drug	Placebo	1
Overall Study	Pharmacodynamic (PD) Population	Brensocatib 10 mg	80
Overall Study	Pharmacodynamic (PD) Population	Brensocatib 25 mg	89
Overall Study	Pharmacodynamic (PD) Population	Placebo	84
Overall Study	COMPLETED	Brensocatib 10 mg	76
Overall Study	COMPLETED	Brensocatib 25 mg	75
Overall Study	COMPLETED	Placebo	74
Overall Study	NOT COMPLETED	Brensocatib 10 mg	6
Overall Study	NOT COMPLETED	Brensocatib 25 mg	12
Overall Study	NOT COMPLETED	Placebo	13

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03218917/flow